Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Revenue

In the fiscal year ending March 31, 2026, Aarti Drugs had annual revenue of 25.68B INR with 7.57% growth. Aarti Drugs had revenue of 7.21B in the quarter ending March 31, 2026, with 6.55% growth.

• Revenue: 25.68B
• Revenue Growth: +7.57%
• P/S Ratio: 1.35
• Revenue / Employee: 20.00M
• Employees: 1,284
• Market Cap: 34.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.68B	1.81B	7.57%
Mar 31, 2025	23.87B	-1.42B	-5.60%
Mar 31, 2024	25.29B	-1.87B	-6.90%
Mar 31, 2023	27.16B	2.27B	9.14%
Mar 31, 2022	24.89B	3.34B	15.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error